^Nishiyama T, Chiba S, Yamada Y (October 2008). "Antinociceptive property of intrathecal and intraperitoneal administration of a novel water-soluble isoindolin-1-one derivative, JM 1232 (-) in rats". European Journal of Pharmacology. 596 (1–3): 56–61.
doi:
10.1016/j.ejphar.2008.07.054.
PMID18708047.
^Kuribayashi J, Kuwana S, Hosokawa Y, Hatori E, Takeda J (2010). "Effect of JM-1232(-), a New Sedative on Central Respiratory Activity in Newborn Rats". New Frontiers in Respiratory Control. Advances in Experimental Medicine and Biology. Vol. 669. pp. 115–118.
doi:
10.1007/978-1-4419-5692-7_23.
ISBN978-1-4419-5691-0.
PMID20217332.
^EP 1566378, Toyooka K, Kanamitsu N, Yoshimura M, Kuriyama H, Tamura T, "Isoindoline Derivative", issued 15 August 2012, assigned to Maruishi Pharmaceutical Co Ltd.
^Nishiyama T, Chiba S, Yamada Y (October 2008). "Antinociceptive property of intrathecal and intraperitoneal administration of a novel water-soluble isoindolin-1-one derivative, JM 1232 (-) in rats". European Journal of Pharmacology. 596 (1–3): 56–61.
doi:
10.1016/j.ejphar.2008.07.054.
PMID18708047.
^Kuribayashi J, Kuwana S, Hosokawa Y, Hatori E, Takeda J (2010). "Effect of JM-1232(-), a New Sedative on Central Respiratory Activity in Newborn Rats". New Frontiers in Respiratory Control. Advances in Experimental Medicine and Biology. Vol. 669. pp. 115–118.
doi:
10.1007/978-1-4419-5692-7_23.
ISBN978-1-4419-5691-0.
PMID20217332.
^EP 1566378, Toyooka K, Kanamitsu N, Yoshimura M, Kuriyama H, Tamura T, "Isoindoline Derivative", issued 15 August 2012, assigned to Maruishi Pharmaceutical Co Ltd.